Recontacting in clinical practice: an investigation of the views of healthcare professionals and clinical scientists in the United Kingdom

Gespeichert in:
Bibliographische Detailangaben
Titel: Recontacting in clinical practice: an investigation of the views of healthcare professionals and clinical scientists in the United Kingdom
Autoren: Daniele Carrieri, Sandi Dheensa, Shane Doheny, Angus J Clarke, Peter D Turnpenny, Anneke M Lucassen, Susan E Kelly
Quelle: Eur J Hum Genet
Verlagsinformationen: Springer Science and Business Media LLC, 2017.
Publikationsjahr: 2017
Schlagwörter: next generation sequencing, Duty to Recontact, 0301 basic medicine, Practice, Health Knowledge, Attitudes, Practice, 0303 health sciences, Attitude of Health Personnel, Health Knowledge, Genetic Counseling, ethics, R1, Article, United Kingdom, 3. Good health, 03 medical and health sciences, Genetic Testing/ethics, Attitudes, Humans, Genetic Testing, Genetic Counseling/ethics, recontact, clinical genetics
Beschreibung: This article explores the views and experiences of healthcare professionals and clinical scientists in genetics about the existence of a duty and/or responsibility to recontact former patients when the genetic information relevant to their health, or that of family members, changes in a potentially important manner. It is based on N=30 semi-structured interviews guided by vignettes of recontacting scenarios. The sample included healthcare professionals in the United Kingdom from different medical specialties (clinical genetics, other 'mainstream' specialties now offering genetic testing), and scientists from regional genetics laboratories. While viewing recontacting as desirable under certain circumstances, most respondents expressed concerns about its feasibility within the current constraints of the National Health Service (NHS). The main barriers identified were insufficient resources (time, staff, and suitable IT infrastructures) and lack of clarity about role boundaries and responsibilities. All of these are further complicated by genetic testing being increasingly offered by mainstream specialties. Reaching a consensus about roles and responsibilities of clinical specialties with regard to recontacting former patients in the light of evolving genetic information, and about what resources and infrastructures would be needed, was generally seen as a pre-requisite to developing guidelines about recontact.
Publikationsart: Article
Conference object
Other literature type
Dateibeschreibung: application/pdf; text
Sprache: English
ISSN: 1476-5438
1018-4813
DOI: 10.1038/ejhg.2016.188
Zugangs-URL: https://europepmc.org/articles/pmc5315519?pdf=render
https://pubmed.ncbi.nlm.nih.gov/28051074
https://orca.cardiff.ac.uk/id/eprint/100620/1/ejhg2016188a.pdf
https://core.ac.uk/display/82959238
https://www.nature.com/articles/ejhg2016188
https://www.nature.com/articles/ejhg2016188.pdf
https://pubmed.ncbi.nlm.nih.gov/28051074/
https://ore.exeter.ac.uk/repository/handle/10871/24800
http://orca.cf.ac.uk/id/eprint/100620
https://eprints.soton.ac.uk/404354/
Rights: CC BY
Dokumentencode: edsair.doi.dedup.....19a34cbab39af0aad1909c08d765e1fc
Datenbank: OpenAIRE
Beschreibung
Abstract:This article explores the views and experiences of healthcare professionals and clinical scientists in genetics about the existence of a duty and/or responsibility to recontact former patients when the genetic information relevant to their health, or that of family members, changes in a potentially important manner. It is based on N=30 semi-structured interviews guided by vignettes of recontacting scenarios. The sample included healthcare professionals in the United Kingdom from different medical specialties (clinical genetics, other 'mainstream' specialties now offering genetic testing), and scientists from regional genetics laboratories. While viewing recontacting as desirable under certain circumstances, most respondents expressed concerns about its feasibility within the current constraints of the National Health Service (NHS). The main barriers identified were insufficient resources (time, staff, and suitable IT infrastructures) and lack of clarity about role boundaries and responsibilities. All of these are further complicated by genetic testing being increasingly offered by mainstream specialties. Reaching a consensus about roles and responsibilities of clinical specialties with regard to recontacting former patients in the light of evolving genetic information, and about what resources and infrastructures would be needed, was generally seen as a pre-requisite to developing guidelines about recontact.
ISSN:14765438
10184813
DOI:10.1038/ejhg.2016.188